Ocugen, Inc. (OCGN) Discusses Top Line Results From Phase II ArMaDa Trial of OCU410 in Geographic Atrophy Transcript By Apex Shark · March 25, 2026 · 1 min read ocgnsa transcripts Source: seekingalpha.com